Hjem › Øcelleadenom › New York
Øcelleadenom kliniske forsøg i New York
4 studier for Øcelleadenom søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Roswell Park Cancer Institute, Buffalo
- Icahan School of Medicine at Mount Sinai, New York
- University of Rochester Medical Center, Rochester
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT06943755A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
- Investigative Site, New York
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06881992Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
- Research Facility, New York
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. mar. 2026 · NCT05477576Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
- Upstate Cancer Center at Oswego, Oswego
- Stony Brook University Medical Center, Stony Brook
- State University of New York Upstate Medical University, Syracuse
- og 3 flere
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 15. dec. 2025 · NCT05040360Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.